MedPath

Outcome of Carbon Dioxide Versus Air Insufflations During Endoscopic Retrograde Cholangiopancreatography (ERCP)

Completed
Conditions
Obstructive Jaundice
Registration Number
NCT01321203
Lead Sponsor
Asian Institute of Gastroenterology, India
Brief Summary

To assess the safety and efficacy of CO2 insufflations during ERCP

1. Primary objective:

To assess the patient's symptoms, abdominal pain and abdominal distension post procedure (ERCP) in the study group.

2. Secondary objective:

Endoscopist:

* To assess the adequacy of bowel distension for adequate luminal visualization

* To assess the peristaltic movement during the ERCP

Anesthetist:

* To measure the PCO2 level in patient post procedure.

* To assess the amount of sedation required during the procedure.

* To assess saturation and vital signs through out the procedure.

* To assess requirement of buscopan.

Detailed Description

mentioned in complete

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
500
Inclusion Criteria
  • All consecutive adult patients referred for ERCP to AIG Hyderabad
Exclusion Criteria
  • Age < 18 years old excluded from the study.
  • Patients with COPD.
  • Patients with poor ejection fractions and decompensated heart failure.
  • Patients with acute illness that require emergency ERCP and not fit for pre procedure and post procedure assessments.
  • Patients with recent endoscopic procedure within 24 hours.
  • Patient with history of recent surgery within 7 days of duration.
  • Pregnant patients.
  • Patients not keen to give consent for the study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patient comfort post ERCP1 hour

the pain score measures using Visual Analog scale (VAs - 1 to 10 cm scale )

Secondary Outcome Measures
NameTimeMethod
Abdominal distention prior and post ERCP5 minutes

The abdominal girth was measured prior to patient shifted to ERCP table. The immdiately post ERCP the abdominal girth measured. A fixed point is marked at the umblical regiem to maintain the site of abdominal girth.

Trial Locations

Locations (1)

Asian Institute Of Gastroenterology India

🇮🇳

Hyderabad, Andra Pradesh, India

Asian Institute Of Gastroenterology India
🇮🇳Hyderabad, Andra Pradesh, India
© Copyright 2025. All Rights Reserved by MedPath